Table 1 Baseline characteristics in prospective uncontrolled clinical trials
Authors | No of P. ovale cases | Age (years) | Sex | Patients’ status | Origin of infection |
|---|---|---|---|---|---|
Siswantoro et al. [18] | 11 | 28 (median) | 8Â M, 3Â F | R | Indonesia |
Same-Ekobo et al. [19] | 30 | – | – | R | Cameroon |
Ringwald et al. [20] | 8 | 17 (median) | – | R | Cameroon |
2 | 8 (median) | – | R | Cameroon | |
Radloff et al. [21] | 3 | >10 years | – | R | Gabon |
Danis et al. [23] | 4 | 19–32 | – | T | Sub-Saharan Africa |